Literature DB >> 15809076

The interaction between tBid and cardiolipin or monolysocardiolipin.

Jihua Liu1, David Durrant, Hung-Sheng Yang, Yongwen He, Francis G Whitby, David G Myszka, Ray M Lee.   

Abstract

Bid, a BH3-only pro-apoptotic member of the Bcl-2 family, is cleaved by caspase 8 in apoptosis induced by death domain receptors. The carboxyl terminus of the cleavage product, tBid, remains associated with the amino terminal fragment (nBid) after cleavage. Dissociation of tBid from nBid occurs during targeting of tBid to mitochondria. We use an in vitro system and demonstrate that cardiolipin is sufficient for the dissociation. Monolysocardiolipin, a metabolite of cardiolipin that increases in mitochondria during apoptosis, has the same affinity to tBid as cardiolipin and is also capable of inducing dissociation of tBid from nBid. In contrast, phosphatidylethanolamine could not induce dissociation of tBid from nBid. To determine the site of tBid that interacts with cardiolipin, we performed mutational analysis by eliminating the positive-charged residues in helices 4-6. None of the single mutations can abolish the ability of tBid to target to mitochondria and to induce cytochrome c release, suggesting that positive-charged residues in helices 4-6 may not be required for mitochondrial targeting of tBid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809076     DOI: 10.1016/j.bbrc.2005.03.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Monolysocardiolipin: improved preparation with high yield.

Authors:  Junhwan Kim; Charles L Hoppel
Journal:  J Lipid Res       Date:  2010-10-19       Impact factor: 5.922

Review 2.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  Phosphatidic acid mediates the targeting of tBid to induce lysosomal membrane permeabilization and apoptosis.

Authors:  Kai Zhao; Hejiang Zhou; Xingyu Zhao; Dennis W Wolff; Yaping Tu; Huili Liu; Taotao Wei; Fuyu Yang
Journal:  J Lipid Res       Date:  2012-07-03       Impact factor: 5.922

4.  C11orf83, a mitochondrial cardiolipin-binding protein involved in bc1 complex assembly and supercomplex stabilization.

Authors:  Marjorie Desmurs; Michelangelo Foti; Etienne Raemy; Frédéric Maxime Vaz; Jean-Claude Martinou; Amos Bairoch; Lydie Lane
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

5.  ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status.

Authors:  Jingsong Cao; Weiqun Shen; Zhijie Chang; Yuguang Shi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-23       Impact factor: 4.310

6.  The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration.

Authors:  Malgorzata Tokarska-Schlattner; Mathieu Boissan; Annie Munier; Caroline Borot; Christiane Mailleau; Oliver Speer; Uwe Schlattner; Marie-Lise Lacombe
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

Review 7.  Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.

Authors:  Anna L Duncan
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

8.  Cardiolipin provides an essential activating platform for caspase-8 on mitochondria.

Authors:  Francois Gonzalvez; Zachary T Schug; Riekelt H Houtkooper; Elaine D MacKenzie; David G Brooks; Ronald J A Wanders; Patrice X Petit; Frédéric M Vaz; Eyal Gottlieb
Journal:  J Cell Biol       Date:  2008-11-10       Impact factor: 10.539

9.  Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo.

Authors:  Anna Manara; Jennefer Lindsay; Marta Marchioretto; Alessandra Astegno; Andrew P Gilmore; Mauro Degli Esposti; Massimo Crimi
Journal:  Biochim Biophys Acta       Date:  2009-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.